Medicus Pharma
MDCX
22 hedge funds and large institutions have $6.48M invested in Medicus Pharma in 2026 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 7 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 3
14% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 7
5% more funds holding
Funds holding: 21 → 22 (+1)
8.14% less ownership
Funds ownership: 15.94% → 7.8% (-8.1%)
88% less capital inflows, than outflows
Capital inflows: $374K | Capital outflows: $3.01M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Interchange Capital Partners
Pittsburgh,
Pennsylvania
|
+$78.3K |
| 2 |
Virtu Financial
New York
|
+$77.3K |
| 3 |
Private Advisor Group
Morristown,
New Jersey
|
+$67.4K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$28.4K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$20.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Armistice Capital
New York
|
-$2.77M |
| 2 |
Jane Street
New York
|
-$92.3K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$61.4K |
| 4 |
HRT Financial
New York
|
-$42K |
| 5 |
Two Sigma Investments
New York
|
-$18.8K |
MDCX Hedge Fund Activity: Q1 2026 in Review
22 of the 8,232 institutional investors tracked by Wall St. Rank reported a position in Medicus Pharma (MDCX) for Q1 2026, worth a combined $6.48M — up 7.6% from $6.03M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new MDCX positions and 7 closed out — a net gain of 1 holder — while 6 added to existing stakes and 3 trimmed.
The largest buyer was Interchange Capital Partners, adding an estimated $78.3K. The largest seller was Armistice Capital, exiting entirely with an estimated $2.77M sold.
- 22 institutional investors held Medicus Pharma (MDCX) as of Q1 2026, up from 21 in Q4 2025.
- Funds reported $6.48M of Medicus Pharma stock for Q1 2026, up 7.6% quarter-over-quarter.
- 8 funds opened new Medicus Pharma positions in Q1 2026 and 7 closed out, a net change of +1 holder.
- The largest Medicus Pharma buyer in Q1 2026 was Interchange Capital Partners, an estimated $78.3K added.
- The largest Medicus Pharma seller in Q1 2026 was Armistice Capital, an estimated $2.77M sold.
Based on aggregated 13F filings for Q1 2026.